IOF publishes first issue of newly revised ‘Progress in Osteoporosis’

NewsGuard 100/100 Score

The International Osteoporosis Foundation (IOF) has published the first issue of the newly revised Progress in Osteoporosis (PIO). Available online on the IOF website at http://www.iofbonehealth.org/sub-hubs/progress-in-osteoporosis, the monthly journal is edited by renowned bone expert and author Professor Ego Seeman of the University of Melbourne.

The free online journal has been revised in terms of design and content, placing increased focus on critical review. A new option invites commentary by readers.

Professor Seeman commented on the journal's revised scope and intention to provide deeper understanding and critical thinking in the bone field. "The purpose of PIO, which began as Advances in Osteoporosis 19 years ago, was to give readers without easy access to research summaries of the most important recent literature. We now inhabit a virtual world. Information is instantaneously accessible to all at the tap of a keyboard. Understanding is not."

The new PIO reflects this development: Its new format continues to provide critical evaluation of the important literature, but now also promotes discussion by inviting assessment of the quality of information published.

IOF COO Judy Stenmark stated, "This is surely the most unique online scientific forum in the bone field. The Editor is renowned for his outspoken critique - and I am certain readers will enjoy the opportunity to participate through online commentary."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Canadian researchers aim to reduce chronic inflammation and comorbidities in HIV patients